(MSM) MSC Industrial Direct - Overview
Stock: Cutting Tools, Abrasives, Measuring Instruments, Fasteners, Safety Supplies
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.07% |
| Yield on Cost 5y | 4.81% |
| Yield CAGR 5y | 3.33% |
| Payout Consistency | 85.7% |
| Payout Ratio | 88.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.4% |
| Relative Tail Risk | -6.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 10.61 |
| Character TTM | |
|---|---|
| Beta | 0.777 |
| Beta Downside | 0.611 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.30% |
| CAGR/Max DD | 0.26 |
Description: MSM MSC Industrial Direct January 08, 2026
MSC Industrial Direct Co., Inc. (NYSE:MSM) is a U.S.-based distributor of metalworking and maintenance-repair-operations (MRO) products, operating across the United States, Canada, Mexico, the United Kingdom, and other international markets.
The company’s catalog spans cutting tools, abrasives, machining fluids, measuring instruments, fasteners, raw materials, power tools, safety supplies, plumbing and material-handling equipment, as well as electrical and power-transmission components. Sales are delivered through traditional print catalogs, a robust e-commerce platform, and a network of fulfillment, regional inventory, and customer-care centers.
MSC serves a diversified client base that includes independent machine shops, large-scale manufacturers, and government agencies, positioning it as a critical supplier in the broader industrial supply chain.
Key recent metrics (FY 2023): revenue of approximately $3.5 billion, operating margin around 7 %, and an inventory turnover of 5.2×-both above the GICS sub-industry median. The business is sensitive to macro drivers such as U.S. manufacturing PMI trends and capital-expenditure cycles, while e-commerce sales have been growing at roughly 15 % YoY, reflecting the sector-wide shift toward digital procurement.
For a deeper quantitative view, you may want to explore MSC’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 204.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -6.65 > 1.0 |
| NWC/Revenue: 14.01% < 20% (prev 15.28%; Δ -1.28% < -1%) |
| CFO/TA 0.11 > 3% & CFO 261.3m > Net Income 204.5m |
| Net Debt (539.8m) to EBITDA (387.5m): 1.39 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.0m) vs 12m ago -0.17% < -2% |
| Gross Margin: 40.73% > 18% (prev 0.41%; Δ 4032 % > 0.5%) |
| Asset Turnover: 153.5% > 50% (prev 153.4%; Δ 0.03% > 0%) |
| Interest Coverage Ratio: 12.56 > 6 (EBITDA TTM 387.5m / Interest Expense TTM 23.4m) |
Altman Z'' 3.15
| A: 0.21 (Total Current Assets 1.26b - Total Current Liabilities 726.3m) / Total Assets 2.49b |
| B: 0.17 (Retained Earnings 426.7m / Total Assets 2.49b) |
| C: 0.12 (EBIT TTM 293.9m / Avg Total Assets 2.48b) |
| D: 0.37 (Book Value of Equity 405.0m / Total Liabilities 1.10b) |
| Altman-Z'' Score: 3.15 = A |
Beneish M -3.01
| DSRI: 1.05 (Receivables 430.7m/407.8m, Revenue 3.81b/3.80b) |
| GMI: 1.01 (GM 40.73% / 41.03%) |
| AQI: 0.97 (AQ_t 0.33 / AQ_t-1 0.34) |
| SGI: 1.00 (Revenue 3.81b / 3.80b) |
| TATA: -0.02 (NI 204.5m - CFO 261.3m) / TA 2.49b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of MSM shares?
Over the past week, the price has changed by +13.30%, over one month by +13.68%, over three months by +13.94% and over the past year by +23.45%.
Is MSM a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MSM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 86 | -10% |
| Analysts Target Price | 86 | -10% |
| ValueRay Target Price | 105.7 | 10.6% |
MSM Fundamental Data Overview February 05, 2026
P/E Forward = 20.5339
P/S = 1.3366
P/B = 3.57
P/EG = 2.186
Revenue TTM = 3.81b USD
EBIT TTM = 293.9m USD
EBITDA TTM = 387.5m USD
Long Term Debt = 213.6m USD (from longTermDebt, last quarter)
Short Term Debt = 338.5m USD (from shortTermDebt, last quarter)
Debt = 580.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 539.8m USD (from netDebt column, last quarter)
Enterprise Value = 5.63b USD (5.09b + Debt 580.0m - CCE 40.3m)
Interest Coverage Ratio = 12.56 (Ebit TTM 293.9m / Interest Expense TTM 23.4m)
EV/FCF = 33.78x (Enterprise Value 5.63b / FCF TTM 166.6m)
FCF Yield = 2.96% (FCF TTM 166.6m / Enterprise Value 5.63b)
FCF Margin = 4.38% (FCF TTM 166.6m / Revenue TTM 3.81b)
Net Margin = 5.37% (Net Income TTM 204.5m / Revenue TTM 3.81b)
Gross Margin = 40.73% ((Revenue TTM 3.81b - Cost of Revenue TTM 2.26b) / Revenue TTM)
Gross Margin QoQ = 40.66% (prev 40.38%)
Tobins Q-Ratio = 2.26 (Enterprise Value 5.63b / Total Assets 2.49b)
Interest Expense / Debt = 0.93% (Interest Expense 5.42m / Debt 580.0m)
Taxrate = 24.30% (16.4m / 67.5m)
NOPAT = 222.5m (EBIT 293.9m * (1 - 24.30%))
Current Ratio = 1.73 (Total Current Assets 1.26b / Total Current Liabilities 726.3m)
Debt / Equity = 0.42 (Debt 580.0m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 1.39 (Net Debt 539.8m / EBITDA 387.5m)
Debt / FCF = 3.24 (Net Debt 539.8m / FCF TTM 166.6m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.25% (Net Income 204.5m / Total Assets 2.49b)
RoE = 14.89% (Net Income TTM 204.5m / Total Stockholder Equity 1.37b)
RoCE = 18.52% (EBIT 293.9m / Capital Employed (Equity 1.37b + L.T.Debt 213.6m))
RoIC = 11.76% (NOPAT 222.5m / Invested Capital 1.89b)
WACC = 7.95% (E(5.09b)/V(5.67b) * Re(8.78%) + D(580.0m)/V(5.67b) * Rd(0.93%) * (1-Tc(0.24)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.66%
[DCF Debug] Terminal Value 74.96% ; FCFF base≈232.1m ; Y1≈189.8m ; Y5≈134.4m
Fair Price DCF = 34.96 (EV 2.49b - Net Debt 539.8m = Equity 1.95b / Shares 55.8m; r=7.95% [WACC]; 5y FCF grow -21.88% → 2.90% )
EPS Correlation: -77.06 | EPS CAGR: -6.82% | SUE: 0.64 | # QB: 0
Revenue Correlation: -2.44 | Revenue CAGR: 3.06% | SUE: 0.21 | # QB: 0
EPS next Quarter (2026-05-31): EPS=1.21 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=8
EPS current Year (2026-08-31): EPS=4.30 | Chg30d=+0.045 | Revisions Net=+7 | Growth EPS=+14.2% | Growth Revenue=+4.9%
EPS next Year (2027-08-31): EPS=4.86 | Chg30d=+0.039 | Revisions Net=+3 | Growth EPS=+13.1% | Growth Revenue=+5.1%